Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tyra Biosciences, Inc.

10.43
+0.10000.97%
Volume:425.19K
Turnover:4.37M
Market Cap:554.65M
PE:-6.38
High:10.43
Open:10.01
Low:10.01
Close:10.33
Loading ...

Tyra Biosciences up 3% as RA Capital increases stake to 22.4%

TIPRANKS
·
12 Jun

RA Capital Management, L.P. Reports Acquisition of Common Shares in Tyra Biosciences Inc

Reuters
·
12 Jun

RA Capital Management Reports Acquisition of Common Shares in Tyra Biosciences Inc

Reuters
·
07 Jun

Tyra Biosciences Inc. Conducted Annual Meeting of Stockholders

Reuters
·
30 May

Bank of America Securities Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
27 May

Tyra Biosciences Coverage Assumed by Piper Sandler at Overweight

Dow Jones
·
21 May

Tyra Bioscience (TYRA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
19 May

Tyra Biosciences Inc. to Participate in UBS Biotech 1x1 Symposium in New York, NY

Reuters
·
13 May

Tyra Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
10 May

BRIEF-Tyra Biosciences Inc Files For Mixed Shelf Of Up To $500 Million - SEC Filing

Reuters
·
09 May

Tyra Biosciences Q1 EPS $(0.47) Beats $(0.48) Estimate

Benzinga
·
09 May

Tyra Biosciences Q1 Basic EPS USD -0.47 VS. Ibes Estimate USD -0.49

THOMSON REUTERS
·
09 May

Tyra Biosciences Inc: Cash Runway Through at Least 2027

THOMSON REUTERS
·
09 May

Tyra Biosciences Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
06 May

Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Mar

Tyra Biosciences Q4 2024 GAAP EPS $(0.43) Beats $(0.47) Estimate

Benzinga
·
28 Mar

Tyra Biosciences reports Q4 EPS (43c) vs. (53c) last year

TIPRANKS
·
28 Mar

Tyra Biosciences Q4 Basic EPS USD -0.43 VS. Ibes Estimate USD -0.48

THOMSON REUTERS
·
28 Mar

Tyra Biosciences: Cash, Cash Equivalents, and Marketable Securities of $341.4 Mln at Ye 2024; Runway Through at Least 2027

THOMSON REUTERS
·
28 Mar

Press Release: Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights

Dow Jones
·
28 Mar